您当前的位置:CN外文-双月刊 > 万方 > 维普 > 知网目次 > 基础医学 >
当代医学科学(英文)(Current Medical Science)(原:华中科技大学学报(医学英德文版))

当代医学科学(英文)(Current Medical Science)(原:华中科技大学学报(医学英德文版)) 万方维普知网目次

基本信息
  • 主管单位:

    教育部

  • 主办单位:

    华中科技大学

  • 国际刊号:

    2096-5230;EISSN2523-899X

  • 国内刊号:

    42-1898/R

  • 学科分类:

    基础医学

  • 字数:

    12000-20000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-双月刊

  • 特殊属性:

    第一批认定学术期刊,外文期刊

联系信息
  • 电话:

    027-83692927(公众号信息)

  • 邮箱:

    tjmu@mails.tjmu.edu.cncms-em@hust.edu.cn(公众号信息)

  • 复合因子:

    0.956

  • 综合因子:

    0.693

  • 收录:

    万方,维普,知网目次

  • 级别:

期刊简介

《当代医学科学(英文)(Current Medical Science)(原:华中科技大学学报(医学英德文版))》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、刊内网址:(202401期)

https://www.springer.com/journal/11596

自动跳转至:

https://link.springer.com/journal/11596/

https://www.editorialmanager.com/tcms/(投稿系统)

3、邮箱:cms-em@hust.edu.cn

cms-em@hust.edu.cn(公众号信息)

4、电话:027-83692927(公众号信息)

5、出刊日期:双月刊,逢双月出版。

2024年4月23日星期二

Current Medical Science期刊介绍

【微信公众号信息】

Current Medical Science 2024-01-12

Current Medical Science

中文刊名:当代医学科学

Current Medical Science,中文刊名:当代医学科学,是一本综合性医学英文SCI期刊,双月出版。2022年JCR影响因子2.4,位于Q3区,被SCI-E、PubMed、MEDLINE、SCOPUS等权威数据库收录。2019年入选中国科技期刊 “卓越行动计划” ,2022年入选湖北省科技期刊 “楚天卓越行动计划”,多次入选“中国最具国际影响力学术期刊(自然科学与工程技术)” 。我刊由华中科技大学主办,与Springer Nature公司合作出版,1979年我刊由已故中国科学院院士裘法祖教授创刊,英文办刊40余年,现任主编为华中科技大学副校长陈建国教授。出版范围涵盖生物医学、临床医学的不同分支学科,重点关注人类疾病发生机制研究和临床试验,长期开设论著、综述等栏目,不定期增设专题、专栏,也欢迎学者们投递Letter to editor,comments等其他类型的论文。

电话:027-83692927

邮箱:cms-em@hust.edu.cn

tjmu@mails.tjmu.edu.cn

地址:武汉市硚口区航空路13号同济医学院期刊部(430030)

官网:link.springer.com/journal/11596

投稿:https://www.editorialmanager.com/tcms/

《当代医学科学(英文版)》投稿须知

【官网信息】

INSTRUCTIONS FOR AUTHORS

Welcome to the electronic manuscript submission website for Current Medical Science (Formerly: Journal of Huazhong University of Science and Technology [Medical Sciences](J Huazhong Univ Sci Technol [Med Sci])). The instructions below are structured so you can quickly and easily answer the following questions:

1. Is my manuscript suitable for Current Medical Science?

2. How do I format my manuscript for Current Medical Science?

3. How do I submit my manuscript to Current Medical Science?

Current Medical Science publishes 6 issues annually and is abstracted or indexed in:

 Web of Science

 PubMed

 Journal Citation Reports/Science Edition

 SCOPUS

 EMBASE

 Chemical Abstracts Service (CAS)

 Google Scholar

 CSA

 Academic OneFile

 Gale

 OCLC

 SCImago

 Summon by Serial Solutions

Editorial policies

Submission to Current Medical Science implies that all authors have read and approved the full manuscript. Corresponding authors of accepted papers will be required to sign a Copyright Transfer Statement on behalf of all authors (see below).

To avoid unnecessary delays in the review process, please study the following policies carefully before submitting your manuscript.

Duplicate publication

Material submitted to the journal must be original and not published or submitted for publication elsewhere in any language. This policy applies to material submitted elsewhere while the contribution to Current Medical Science is under consideration.

Authors submitting a manuscript should notify the editor(s) if part of their contribution has appeared or will appear elsewhere, or if any related material is under consideration or in press elsewhere.

If a submission contains a figure that has been published elsewhere or that has been copy-righted, the author must provide documentation that the previous publisher or copyright holder has given permission for the figure to be re-published. The editors consider all material in good faith, and assume that the journal has full permission to publish every part of the submitted material, including illustrations.

Conflicts of interest

In the interests of transparency and to help reviewers assess any potential bias, the journal requires authors of research articles to declare any competing commercial interests in relation to the submitted work. Referees are also asked to indicate any potential conflict they might have with reviewing a particular paper.

Research Data Policy and Data Availability Statements

A submission to the journal implies that materials described in the manuscript, including all relevant raw data, will be freely available to any researcher wishing to use them for non-commercial purposes, without breaching participant confidentiality.

Data availability

All original research must include a data availability statement. Data availability statements should include information on where data supporting the results reported in the article can be found, if applicable. Statements should include, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. For the purposes of the data availability statement, “data” is defined as the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. When it is not possible to share research data publicly, for instance when individual privacy could be compromised, data availability should still be stated in the manuscript along with any conditions for access.

Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):

1. The datasets generated during and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]

2. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

3. All data generated or analysed during this study are included in this published article [and its supplementary information files].

4. The datasets generated during and/or analysed during the current study are not publicly available due [REASON(S) WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.].

5. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

6. The data that support the findings of this study are available from [THIRD PARTY NAME] but restrictions apply to the availability of these data, which were used under licence for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [THIRD PARTY NAME].

More templates for data availability statements, including examples of openly available and restricted access datasets, are available here:

……

更多详情请查看期刊官网信息。


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。